Growth Metrics

Sanofi (SNY) Non-Current Assets (2016 - 2026)

Sanofi's Non-Current Assets history spans 18 years, with the latest figure at $114.6 billion for Q1 2026.

  • On a quarterly basis, Non-Current Assets rose 23.95% to $114.6 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $114.6 billion, a 23.95% increase, with the full-year FY2025 number at $111.6 billion, up 15.75% from a year prior.
  • Non-Current Assets hit $114.6 billion in Q1 2026 for Sanofi, up from $111.6 billion in the prior quarter.
  • Over the last five years, Non-Current Assets for SNY hit a ceiling of $114.6 billion in Q1 2026 and a floor of $92.4 billion in Q1 2025.
  • Historically, Non-Current Assets has averaged $103.1 billion across 5 years, with a median of $103.1 billion in 2023.
  • Biggest five-year swings in Non-Current Assets: skyrocketed 3449.41% in 2022 and later dropped 7.26% in 2025.
  • Tracing SNY's Non-Current Assets over 5 years: stood at $94.5 billion in 2022, then rose by 9.08% to $103.1 billion in 2023, then dropped by 6.47% to $96.4 billion in 2024, then increased by 15.75% to $111.6 billion in 2025, then rose by 2.68% to $114.6 billion in 2026.
  • Business Quant data shows Non-Current Assets for SNY at $114.6 billion in Q1 2026, $111.6 billion in Q4 2025, and $111.9 billion in Q3 2025.